AAAAAA
Results: 1-25/42
Authors:
MOELLENTINE C
RUMMANS T
AHLSKOG JE
HARMSEN WS
SUMAN VJ
OCONNOR MK
BLACK JL
PILEGGI T
Citation: C. Moellentine et al., EFFECTIVENESS OF ECT IN PATIENTS WITH PARKINSONISM, The Journal of neuropsychiatry and clinical neurosciences, 10(2), 1998, pp. 187-193
Authors:
DEWEY RB
MARAGANORE DM
AHLSKOG JE
MATSUMOTO JY
Citation: Rb. Dewey et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF INTRANASAL APOMORPHINE SPRAY AS A RESCUE AGENT FOR OFF-STATES IN PARKINSONS-DISEASE, Movement disorders, 13(5), 1998, pp. 782-787
Authors:
CHABOLLA DR
MARAGANORE DM
AHLSKOG JE
OBRIEN PC
ROCCA WA
Citation: Dr. Chabolla et al., DRUG-INDUCED PARKINSONISM AS A RISK FACTOR FOR PARKINSONS-DISEASE - AHISTORICAL COHORT STUDY IN OLMSTED COUNTY, MINNESOTA, Mayo Clinic proceedings, 73(8), 1998, pp. 724-727
Authors:
KOMPOLITI K
GOETZ CG
BOEVE BF
MARAGANORE DM
AHLSKOG JE
MARSDEN CD
BHATIA KP
GREENE PE
PRZEDBORSKI S
SEAL EC
BURNS RS
HAUSER RA
GAUGER LL
FACTOR SA
MOLHO ES
RILEY DE
Citation: K. Kompoliti et al., CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICOBASAL DEGENERATION, Archives of neurology, 55(7), 1998, pp. 957-961
Authors:
KOCH LD
COFIELD RH
AHLSKOG JE
Citation: Ld. Koch et al., TOTAL SHOULDER ARTHROPLASTY IN PATIENTS WITH PARKINSONS-DISEASE, Journal of shoulder and elbow surgery, 6(1), 1997, pp. 24-28
Authors:
BOEVE BF
PARISI JE
MARAGANORE DM
AHLSKOG JE
CASELLI RJ
GRAFFRADFORD NR
PETERSEN RC
KOKMEN E
Citation: Bf. Boeve et al., PATHOLOGICAL FINDINGS IN 11 CASES OF CLINICALLY SUSPECTED CORTICAL-BASAL GANGLIONIC DEGENERATION (CBGD), Brain pathology, 7(4), 1997, pp. 1177-1177
Authors:
UITTI RJ
RAJPUT AH
AHLSKOG JE
OFFORD KP
SCHROEDER DR
HO MM
PRASAD M
RAJPUT A
BASRAN P
Citation: Rj. Uitti et al., AMANTADINE TREATMENT IS AN INDEPENDENT PREDICTOR OF IMPROVED SURVIVALIN PARKINSONS-DISEASE, Nervenheilkunde, 16(7), 1997, pp. 417-423
Authors:
LOW PA
AHLSKOG JE
PETERSON RC
WARING C
ESTEBANSANTILLAN C
KURLAND LT
Citation: Pa. Low et al., AUTONOMIC FAILURE IN GUAMANIAN NEURODEGENERATIVE DISEASE, Neurology, 49(4), 1997, pp. 1031-1034
Authors:
AHLSKOG JE
PETERSEN RC
WARING SC
ESTEBANSANTILLAN C
CRAIG UK
MARAGANORE DM
LENNON VA
KURLAND LT
Citation: Je. Ahlskog et al., GUAMANIAN NEURODEGENERATIVE DISEASE - ARE DIABETES-MELLITUS AND ALTERED HUMORAL IMMUNITY CLUES TO PATHOGENESIS, Neurology, 48(5), 1997, pp. 1356-1362
Authors:
KUMAR R
MARAGANORE DM
AHLSKOG JE
RODRIGUEZ M
Citation: R. Kumar et al., TREATMENT OF PUTATIVE IMMUNE-MEDIATED AND IDIOPATHIC CERVICAL DYSTONIA WITH INTRAVENOUS METHYLPREDNISOLONE, Neurology, 48(3), 1997, pp. 732-735
Authors:
UITTI RJ
AHLSKOG JE
Citation: Rj. Uitti et Je. Ahlskog, COMPARATIVE REVIEW OF DOPAMINE-RECEPTOR AGONISTS IN PARKINSONS-DISEASE (VOL 5, PG 369, 1996), CNS DRUGS, 6(3), 1996, pp. 203-203
Authors:
UITTI RJ
AHLSKOG JE
Citation: Rj. Uitti et Je. Ahlskog, COMPARATIVE REVIEW OF DOPAMINE-RECEPTOR AGONISTS IN PARKINSONS-DISEASE, CNS DRUGS, 5(5), 1996, pp. 369-388
Authors:
UITTI RJ
AHLSKOG JE
MARAGANORE DM
Citation: Rj. Uitti et al., DOES LEVODOPA THERAPY DELAY DEATH IN PARKINSONS-DISEASE, Movement disorders, 11(3), 1996, pp. 343-344
Authors:
DEWEY RB
MARAGANORE DM
AHLSKOG JE
MATSUMOTO JY
Citation: Rb. Dewey et al., INTRANASAL APOMORPHINE RESCUE THERAPY FOR PARKINSONIAN OFF PERIODS, Clinical neuropharmacology, 19(3), 1996, pp. 193-201
Authors:
AHLSKOG JE
WRIGHT KF
MUENTER MD
ADLER CH
Citation: Je. Ahlskog et al., ADJUNCTIVE CABERGOLINE THERAPY OF PARKINSONS-DISEASE - COMPARISON WITH PLACEBO AND ASSESSMENT OF DOSE RESPONSES AND DURATION OF EFFECT, Clinical neuropharmacology, 19(3), 1996, pp. 202-212
Authors:
UITTI RJ
RAJPUT AH
AHLSKOG JE
OFFORD KP
SCHROEDER DR
HO MM
PRASAD M
RAJPUT A
BASRAN P
Citation: Rj. Uitti et al., AMANTADINE TREATMENT IS AN INDEPENDENT PREDICTOR OF IMPROVED SURVIVALIN PARKINSONS-DISEASE, Neurology, 46(6), 1996, pp. 1551-1556
Authors:
HUTTON JT
KOLLER WC
AHLSKOG JE
PAHWA R
HURTIG HI
STERN MB
HINER BC
LIEBERMAN A
PFEIFFER RF
RODNITZKY RL
WATERS CH
MUENTER MD
ADLER CH
MORRIS JL
Citation: Jt. Hutton et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 46(4), 1996, pp. 1062-1065
Authors:
AHLSKOG JE
UITTI RJ
LOW PA
TYCE GM
OBRIEN JF
NICKANDER KK
Citation: Je. Ahlskog et al., LEVODOPA AND DEPRENYL TREATMENT EFFECTS ON PERIPHERAL INDEXES OF OXIDANT STRESS IN PARKINSONS-DISEASE, Neurology, 46(3), 1996, pp. 796-801
Authors:
AHLSKOG JE
Citation: Je. Ahlskog, TREATMENT OF EARLY PARKINSONS-DISEASE - ARE COMPLICATED STRATEGIES JUSTIFIED, Mayo Clinic proceedings, 71(7), 1996, pp. 659-670
Authors:
AHLSKOG JE
UITTI RJ
TYCE GM
OBRIEN JF
PETERSEN RC
KOKMEN E
Citation: Je. Ahlskog et al., PLASMA CATECHOLS AND MONOAMINE-OXIDASE METABOLITES IN UNTREATED PARKINSONS AND ALZHEIMERS DISEASES, Journal of the neurological sciences, 136(1-2), 1996, pp. 162-168
Authors:
MOELLENTINE CK
RUMMANS TA
AHLSKOG JE
OCONNOR K
HARMSEN WS
SUMAN V
Citation: Ck. Moellentine et al., ECT AND PARKINSONS-DISEASE, The American journal of geriatric psychiatry, 3(3), 1995, pp. 267-268
Authors:
AHLSKOG JE
UITTI RJ
LOW PA
TYCE GM
NICKANDER KK
PETERSEN RC
KOKMEN E
Citation: Je. Ahlskog et al., NO EVIDENCE FOR SYSTEMIC OXIDANT STRESS IN PARKINSONS OR ALZHEIMERS-DISEASE, Movement disorders, 10(5), 1995, pp. 566-573
Authors:
DEWEY RB
MARAGANORE DM
AHLSKOG JE
MATSUMOTO JY
Citation: Rb. Dewey et al., A CONTROLLED CLINICAL-TRIAL OF INTRANASAL APOMORPHINE AS RESCUE THERAPY FOR OFF PERIODS IN FLUCTUATING PARKINSONS-DISEASE, Annals of neurology, 38(2), 1995, pp. 329-329
GUAMANIAN NEURODEGENERATIVE DISEASE - INVESTIGATION OF THE CALCIUM-METABOLISM HEAVY-METAL HYPOTHESIS
Authors:
AHLSKOG JE
WARING SC
KURLAND LT
PETERSEN RC
MOYER TP
HARMSEN WS
MARAGANORE DM
OBRIEN PC
ESTEBANSANTILLAN C
BUSH V
Citation: Je. Ahlskog et al., GUAMANIAN NEURODEGENERATIVE DISEASE - INVESTIGATION OF THE CALCIUM-METABOLISM HEAVY-METAL HYPOTHESIS, Neurology, 45(7), 1995, pp. 1340-1344
Authors:
BHARUCHA KJ
PARISI JE
MARAGANORE DM
AHLSKOG JE
Citation: Kj. Bharucha et al., A CLINICOPATHOLOGICAL, POPULATION-BASED STUDY OF DEMENTIA IN PARKINSONS-DISEASE, Neurology, 45(4), 1995, pp. 339-339